• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙通道拮抗剂的晶体结构:2,6 - 二甲基 - 3,5 - 二羧酸甲酯基 - 4 - [2 - 硝基 -、3 - 氰基 -、4 -(二甲氨基) - 和2,3,4,5,6 - 五氟苯基] - 1,4 - 二氢吡啶

Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.

作者信息

Triggle A M, Shefter E, Triggle D J

出版信息

J Med Chem. 1980 Dec;23(12):1442-5. doi: 10.1021/jm00186a029.

DOI:10.1021/jm00186a029
PMID:6256552
Abstract

The crystal structures of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-nitrophenyl)-1,4-dihydropyridine (Nifedipine) and the 3-cyano-, 4-(dimethylamino)- and 2,3,4,5,6-pentafluorophenyl derivatives were determined. The 1,4-dihydropyridine ring in all four compounds has a boat-type conformation with varying degrees of puckering at the C4 position. Increasing distortion from planarity at this position shows a limited correlation with decreasing biological activity, determined as the ability to inhibit the Ca2+-dependent muscarinic-induced mechanical responses of guinea pig ileal longitudinal smooth muscle.

摘要

测定了2,6-二甲基-3,5-二甲氧羰基-4-(2-硝基苯基)-1,4-二氢吡啶(硝苯地平)及其3-氰基、4-(二甲氨基)和2,3,4,5,6-五氟苯基衍生物的晶体结构。所有四种化合物中的1,4-二氢吡啶环均呈船型构象,C4位有不同程度的褶皱。该位置平面度的畸变增加与生物活性降低存在有限的相关性,生物活性通过抑制豚鼠回肠纵行平滑肌Ca2+依赖性毒蕈碱诱导的机械反应的能力来确定。

相似文献

1
Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.钙通道拮抗剂的晶体结构:2,6 - 二甲基 - 3,5 - 二羧酸甲酯基 - 4 - [2 - 硝基 -、3 - 氰基 -、4 -(二甲氨基) - 和2,3,4,5,6 - 五氟苯基] - 1,4 - 二氢吡啶
J Med Chem. 1980 Dec;23(12):1442-5. doi: 10.1021/jm00186a029.
2
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.钙通道拮抗剂的晶体结构与药理活性:2,6 - 二甲基 - 3,5 - 二羧酸甲酯基 - 4 -(未取代、2 - 甲基、4 - 甲基、3 - 硝基、4 - 硝基以及2,4 - 二硝基苯基)- 1,4 - 二氢吡啶
J Med Chem. 1982 Feb;25(2):126-31. doi: 10.1021/jm00344a007.
3
Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.硝苯地平的1,2 - 二氢吡啶类似物的合成及钙通道拮抗剂活性
Drug Des Deliv. 1988 Nov;3(3):245-56.
4
Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.含有1,2 - 二氢吡啶基取代1,4 - 二氢吡啶部分的硝苯地平类似物的合成及钙通道拮抗剂活性
Drug Des Deliv. 1988 Feb;2(3):177-89.
5
Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series.异丁基甲基 2,6 - 二甲基 - 4 -(取代苯基)- 1,4 - 二氢吡啶 - 3,5 - 二羧酸酯(尼索地平)系列1,4 - 二氢吡啶类钙通道拮抗剂的晶体结构与药理活性
J Med Chem. 1988 Feb;31(2):300-5. doi: 10.1021/jm00397a005.
6
Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-3,5-pyridinedicarboxylates.
J Med Chem. 1986 Dec;29(12):2524-9. doi: 10.1021/jm00162a016.
7
Molecular properties of the slow inward calcium channel. Molecular weight determinations by radiation inactivation and covalent affinity labeling.
J Biol Chem. 1983 Aug 10;258(15):9344-8.
8
Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.1,4-二氢-2,6-二甲基-3-硝基-4-吡啶基吡啶-5-羧酸异丙酯外消旋体和对映体的合成、钙通道激动剂-拮抗剂调节活性及电压钳研究
J Med Chem. 1995 Jul 21;38(15):2851-9. doi: 10.1021/jm00015a007.
9
Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.钙通道调节:抑制或促进钙内流的能力存在于同一个二氢吡啶分子中。
J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1170-6.
10
o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.邻异硫氰酸酯二氢吡啶(oNCS-DHP),一种长效、可逆的钙离子通道抑制剂。
J Pharmacol Exp Ther. 1986 Sep;238(3):1084-91.

引用本文的文献

1
Exploring the thermal behaviour of the solvated structures of nifedipine.探讨硝苯地平溶剂化结构的热行为。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2023 Apr 1;79(Pt 2):164-175. doi: 10.1107/S2052520623001282. Epub 2023 Mar 9.
2
Nanomechanical properties of selected single pharmaceutical crystals as a predictor of their bulk behaviour.所选单一药物晶体的纳米力学性质作为其整体行为的预测指标。
Pharm Res. 2015 Feb;32(2):469-81. doi: 10.1007/s11095-014-1475-3. Epub 2014 Aug 5.
3
Nifedipine-pyrazine (2/1).硝苯地平-吡嗪(2/1)
Acta Crystallogr Sect E Struct Rep Online. 2010 Aug 11;66(Pt 9):o2297-8. doi: 10.1107/S1600536810031703.
4
3,5-Bis(ethoxy-carbon-yl)-2,6-dimethyl-1,4-dihydro-pyridine-4-carboxylic acid.3,5-双(乙氧基羰基)-2,6-二甲基-1,4-二氢吡啶-4-羧酸
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 4;65(Pt 8):o1748. doi: 10.1107/S1600536809024945.
5
Diethyl 4-[4-(dimethyl-amino)phen-yl]-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ate.4-[4-(二甲基氨基)苯基]-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二乙酯
Acta Crystallogr Sect E Struct Rep Online. 2010 Feb 6;66(Pt 3):o519. doi: 10.1107/S1600536810003508.
6
1,1'-[4-(2,4-Dichloro-phen-yl)-2,6-di-methyl-1,4-di-hydro-pyridine-3,5-di-yl]diethanone.1,1'-[4-(2,4-二氯苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二基]二乙酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 15;67(Pt 2):o380-1. doi: 10.1107/S1600536810052839.
7
A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers.二氢吡啶类钙通道阻滞剂晶相和非晶相中氢键模式的光谱研究。
Pharm Res. 2002 Apr;19(4):477-83. doi: 10.1023/a:1015147729564.
8
Comparative molecular modelling study of the calcium channel blockers nifedipine and black mamba toxin FS2.
J Comput Aided Mol Des. 1997 Sep;11(5):491-501. doi: 10.1023/a:1007974124426.
9
Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.
Pharm Res. 1994 Dec;11(12):1766-70. doi: 10.1023/a:1018971501909.
10
A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.豚鼠心脏、肝脏和肾脏线粒体膜上的一个新型1,4 - 二氢吡啶结合位点。
Biochem J. 1988 Jul 1;253(1):49-58. doi: 10.1042/bj2530049.